Metatranscriptomic analysis indicates prebiotic effect of isomalto/malto-polysaccharides on human colonic microbiota

Klaudyna Borewicz1,2, Bastian Hornung3,4,5, Fangjie Gu6,7

  • 1Laboratory of Microbiology, Wageningen University & Research, Stippeneng 4, 6708 WE, Wageningen, The Netherlands.

Scientific Reports
|August 14, 2024
PubMed

Insights

Isomalto/malto-polysaccharides (IMMPs) are novel soluble dietary fibers. This study reveals how IMMPs with specific linkages influence gut microbial gene expression and promote beneficial bacteria like Lactobacillus and Bifidobacterium.

Area of Science:

  • Microbiology
  • Nutritional Science
  • Biochemistry

Background:

  • Isomalto/malto-polysaccharides (IMMPs) are soluble dietary fibers with demonstrated prebiotic potential.
  • Previous research indicated IMMPs increase gut bacteria, particularly lactobacilli, and short-chain fatty acid (SCFA) production.
  • The precise mechanism by which IMMPs exert their prebiotic effects remains unclear.

Purpose of the Study:

  • To investigate the impact of IMMPs with varying α-(1→6) glycosidic linkages on gut microbial function.
  • To elucidate the mode of action of IMMPs using metatranscriptomics.
  • To identify specific gut bacteria involved in IMMP degradation and their functional responses.

Main Methods:

  • In vitro fermentation of IMMPs with human fecal inoculum.
  • Metatranscriptomic analysis to assess microbial gene expression profiles.
  • Analysis of bacterial community dynamics and relative abundance.

Main Results:

  • Microbial community dynamics and gene expression varied based on IMMP type and α-(1→6) linkage content.
  • Bacteroides, Lactobacillus, and Bifidobacterium were identified as primary IMMP degraders.
  • Increased gene expression in these bacteria correlated with higher α-(1→6) linkages, alongside enhanced SCFA synthesis pathways.

Conclusions:

  • IMMP fermentation alters gut microbial community structure and function, with specific linkages driving these changes.
  • The study provides insights into the targeted modulation of beneficial gut bacteria by IMMPs.
  • Findings support the rational design of prebiotics for specific health outcomes.

Related Concept Videos

Introduction to the Human Microbiota01:22

Introduction to the Human Microbiota

Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity, and disease...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Microbiota of the Large Intestine01:27

Microbiota of the Large Intestine

The large intestine hosts the most densely populated microbial ecosystem in the human body. This complex community primarily consists of anaerobic bacteria, with Bacillota (formerly Firmicutes) and Bacteroidota (formerly Bacteroidetes) as the predominant groups. The distribution of these microbes varies along different sections of the large intestine, influenced by local environmental factors such as oxygen availability and nutrient composition.The cecum, located at the beginning of the large...
Functions of the Gut Microbiota01:18

Functions of the Gut Microbiota

The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...
Dysbiosis of the Gut Microbiota01:18

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...